These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Novel interferons for treatment of hepatitis C virus. Clark V; Nelson DR Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153 [TBL] [Abstract][Full Text] [Related]
65. Gene activation by interferon. Cancer J Sci Am; 1995; 1(4):295-6. PubMed ID: 16998975 [No Abstract] [Full Text] [Related]
66. Viral chemotherapy: its promise and problems. Borden EC; Carter WA Medicine (Baltimore); 1972 May; 51(3):189-90. PubMed ID: 4401797 [No Abstract] [Full Text] [Related]
67. [Problems on "interferon" as a medicine: -- a view point of an investigatar participating in its developement-- (author's transl)]. Kohno S Tanpakushitsu Kakusan Koso; 1976 Apr; 21(4):328-333. PubMed ID: 1034951 [No Abstract] [Full Text] [Related]
68. Development of gene-specific double-stranded RNA drugs. Barik S Ann Med; 2004; 36(7):540-51. PubMed ID: 15513304 [TBL] [Abstract][Full Text] [Related]
69. Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: implications for prevention and therapy of viral diseases and cancer. Fernandez-Pol JA; Hamilton PD; Klos DJ Anticancer Res; 2001; 21(2A):931-57. PubMed ID: 11396187 [TBL] [Abstract][Full Text] [Related]
70. [Chemotherapy of virus diseases]. Bock M Curr Top Microbiol Immunol; 1967; 41():100-43. PubMed ID: 4862181 [No Abstract] [Full Text] [Related]
71. [Recent aspects of antiviral therapy]. Wacker A Verh Dtsch Ges Inn Med; 1971; 77():850-6. PubMed ID: 4949706 [No Abstract] [Full Text] [Related]
72. The interferon-inducible, double-stranded RNA-specific adenosine deaminase gene (DSRAD) maps to human chromosome 1q21.1-21.2. Weier HU; George CX; Greulich KM; Samuel CE Genomics; 1995 Nov; 30(2):372-5. PubMed ID: 8586444 [TBL] [Abstract][Full Text] [Related]
73. [Interferon as a therapeutic agent]. Borecký L Cesk Farm; 1982 Jun; 31(5):184-7. PubMed ID: 6180842 [No Abstract] [Full Text] [Related]
74. [Interferon, its clinical significance and use]. Bektemirov TA; Shul'tsev GP Ter Arkh; 1973 Jan; 45(1):10-5. PubMed ID: 4588910 [No Abstract] [Full Text] [Related]
75. [Interferon: biosynthesis, characteristics and mechanism of action]. Bodo G Wien Klin Wochenschr; 1969 Aug; 81(31):571-6. PubMed ID: 4999050 [No Abstract] [Full Text] [Related]
76. The interferon system as a basis for antiviral therapy or prophylaxis. Billiau A Verh K Acad Geneeskd Belg; 1986; 48(3):187-220. PubMed ID: 2430375 [No Abstract] [Full Text] [Related]
77. A review of approaches to viral chemotherapy. Gordon M; Buchanan RL; Crenshaw RR; Kerridge KA; MacNintch JE; Siminoff P J Med; 1981; 12(5):289-382. PubMed ID: 6171603 [No Abstract] [Full Text] [Related]
78. [Perspectives on interferon research and on its therapeutic use]. Montagnier L Arch Inst Pasteur Tunis; 1981; 58(3):297-312. PubMed ID: 6172080 [TBL] [Abstract][Full Text] [Related]
79. [Effect of remantadine and ribavirin on the production and antiviral action of human interferon types I and II]. Nosik DN; Aspetov RD; Novokhatskiĭ AS Antibiotiki; 1982 Jan; 27(1):49-54. PubMed ID: 6174074 [TBL] [Abstract][Full Text] [Related]